BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 35845294)

  • 1. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
    Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
    JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Where does TIPS fit in the management of patients with cirrhosis?
    García-Pagán JC; Saffo S; Mandorfer M; Garcia-Tsao G
    JHEP Rep; 2020 Aug; 2(4):100122. PubMed ID: 32671331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
    Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
    J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis.
    Larrue H; D'Amico G; Olivas P; Lv Y; Bucsics T; Rudler M; Sauerbruch T; Hernandez-Gea V; Han G; Reiberger T; Thabut D; Vinel JP; Péron JM; García-Pagán JC; Bureau C
    J Hepatol; 2023 Sep; 79(3):692-703. PubMed ID: 37141993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.
    Shah AS; Amarapurkar DN
    J Clin Exp Hepatol; 2018 Mar; 8(1):50-57. PubMed ID: 29743797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.
    Torp N; Israelsen M; Madsen B; Lutz P; Jansen C; Strassburg C; Mortensen C; Knudsen AW; Sorensen GL; Holmskov U; Schlosser A; Thiele M; Trebicka J; Krag A
    JHEP Rep; 2021 Jun; 3(3):100287. PubMed ID: 34041469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.
    Praktiknjo M; Abu-Omar J; Chang J; Thomas D; Jansen C; Kupczyk P; Schepis F; Garcia-Pagan JC; Merli M; Meyer C; Strassburg CP; Pieper CC; Trebicka J
    JHEP Rep; 2021 Jun; 3(3):100264. PubMed ID: 34013182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites.
    Hu XG; Yang XX; Lu J; Li G; Dai JJ; Wang JM; Deng Y; Feng R
    World J Gastrointest Surg; 2024 Feb; 16(2):481-490. PubMed ID: 38463353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLIF-C AD score predicts survival benefit from pre-emptive TIPS in individuals with Child-Pugh B cirrhosis and acute variceal bleeding.
    Lv Y; Bai W; Zhu X; Xue H; Zhao J; Zhuge Y; Sun J; Zhang C; Ding P; Jiang Z; Zhu X; Ren W; Li Y; Zhang K; Zhang W; Li K; Wang Z; Luo B; Li X; Yang Z; Wang Q; Guo W; Xia D; Yang C; Pan Y; Yin Z; Fan D; Han G
    JHEP Rep; 2022 Dec; 4(12):100621. PubMed ID: 36439638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
    Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
    Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.
    Pitton MB; Zimmermann T; Mildenberger P; Weinmann A; Kloeckner R; Düber C; Mittler J; Hoppe-Lotichius M; Otto G
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e214-e222. PubMed ID: 33230020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis.
    Wirtz TH; Reuken PA; Jansen C; Fischer P; Bergmann I; Backhaus C; Emontzpohl C; Reißing J; Brandt EF; Koenen MT; Schneider KM; Schierwagen R; Brol MJ; Chang J; Zimmermann HW; Köse-Vogel N; Eggermann T; Kurth I; Stoppe C; Bucala R; Bernhagen J; Praktiknjo M; Stallmach A; Trautwein C; Trebicka J; Bruns T; Berres ML
    JHEP Rep; 2021 Apr; 3(2):100221. PubMed ID: 33659891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunt (TIPS) placement at index portal hypertensive decompensation (anticipant TIPS) in cirrhosis and the role of early intervention in variceal bleeding and ascites.
    Rajesh S; Philips CA; Betgeri SS; George T; Ahamed R; Mohanan M; Augustine P
    Indian J Gastroenterol; 2021 Aug; 40(4):361-372. PubMed ID: 34324168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study.
    Lv Y; Zuo L; Zhu X; Zhao J; Xue H; Jiang Z; Zhuge Y; Zhang C; Sun J; Ding P; Ren W; Li Y; Zhang K; Zhang W; He C; Zhong J; Peng Q; Ma F; Luo J; Zhang M; Wang G; Sun M; Dong J; Bai W; Guo W; Wang Q; Yuan X; Wang Z; Yu T; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Li K; Yin Z; Nie Y; Fan D; Han G
    Gut; 2019 Jul; 68(7):1297-1310. PubMed ID: 30415233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score.
    Chang J; Höfer P; Böhling N; Lingohr P; Manekeller S; Kalff JC; Dohmen J; Kaczmarek DJ; Jansen C; Meyer C; Strassburg CP; Trebicka J; Praktiknjo M
    JHEP Rep; 2022 Mar; 4(3):100442. PubMed ID: 35198929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.
    Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Brujats A; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J;
    J Hepatol; 2021 Sep; 75(3):589-599. PubMed ID: 33905794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study.
    Kumar U; Kumar R; Jha SK; Jha AK; Dayal VM; Kumar A
    Indian J Gastroenterol; 2020 Oct; 39(5):457-464. PubMed ID: 33175368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Status at Liver Transplant Waitlisting Correlates With Greater Odds of Encephalopathy, Ascites, and Spontaneous Bacterial Peritonitis.
    McCabe P; Hirode G; Wong R
    J Clin Exp Hepatol; 2020; 10(5):413-420. PubMed ID: 33029049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
    Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.